[Fasudil(Rho-kinase inhibitor)].
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine.
Yoshihiro
Y
Fukumoto
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy*; D051379:Mice; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D054460:rho-Associated Kinases / Q000037:antagonists & inhibitors*
D047428:Protein Kinase Inhibitors; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D054460:rho-Associated Kinases; C049347:fasudil